FILE PHOTO: A nurse checks a patient's temperature in a coronavirus disease (COVID-19) testing clinic at Westmead Hospital in Sydney, Australia, May 12, 2020. REUTERS/Loren Elliott
SYDNEY (Reuters) - An experimental drug developed by an Australian researcher could help prevent deaths from COVID-19 by controlling the formation of blood clots responsible for breathing difficulties, organ failure, stroke and heart attack.
Professor Shaun Jackson from the University of Sydney and the Heart Research Institute is leading a team of researchers developing a new anti-clotting medicine to treat stroke.
Already a subscriber? Log in.
Save 30% for ads-free and full access now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
